Search research articles
Contact Us
Filters
Showing results (171-180 of 531) with videos related to
Page
of 54
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 3, 2016
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci
Jordan R Smith, Juwon Yim, Animesh Raut, et al.
Antimicrobial Agents and Chemotherapy
|
February 27, 1999
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods
E Hershberger, J R Aeschlimann, T Moldovan, et al.
International Journal of Antimicrobial Agents
|
July 19, 2011
In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates
Celine Vidaillac, Jorge Parra-Ruiz, Patricia Winterfield, et al.
Fysiatricky a Reumatologicky Vestnik
|
December 1, 1975
[Rehabilitation of children with chronic progessive polyarthritis in the home]
K Kujawska, E Musiej-Nowakowska, J Rybak, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 15, 2020
A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli
Taylor Morrisette, Abdalhamid M Lagnf, Sara Alosaimy, et al.
Drug Intelligence & Clinical Pharmacy
|
January 1, 1983
Zomepirac-related acute renal failure
S C Boike, M J Rybak, J E Tintinalli, et al.
Antimicrobial Agents and Chemotherapy
|
October 19, 2000
Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model
J R Aeschlimann, G P Allen, E Hershberger, et al.
Antimicrobial Agents and Chemotherapy
|
June 30, 2010
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates
Kimberly D Leuthner, Celine Vidaillac, Chrissy M Cheung, et al.
Pharmacotherapy
|
November 11, 1999
Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside
K R Murry, P S McKinnon, B Mitrzyk, et al.
Antimicrobial Agents and Chemotherapy
|
March 11, 2015
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models
Jordan R Smith, Katie E Barber, Animesh Raut, et al.
Page
of 54
Search research articles
Search
Showing results (171-180 of 531) with videos related to
Sort By:
Page
of 54
Antimicrobial Agents and Chemotherapy
|
February 3, 2016
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci
Jordan R Smith, Juwon Yim, Animesh Raut, et al.
Antimicrobial Agents and Chemotherapy
|
February 27, 1999
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods
E Hershberger, J R Aeschlimann, T Moldovan, et al.
International Journal of Antimicrobial Agents
|
July 19, 2011
In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates
Celine Vidaillac, Jorge Parra-Ruiz, Patricia Winterfield, et al.
Fysiatricky a Reumatologicky Vestnik
|
December 1, 1975
[Rehabilitation of children with chronic progessive polyarthritis in the home]
K Kujawska, E Musiej-Nowakowska, J Rybak, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 15, 2020
A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli
Taylor Morrisette, Abdalhamid M Lagnf, Sara Alosaimy, et al.
Drug Intelligence & Clinical Pharmacy
|
January 1, 1983
Zomepirac-related acute renal failure
S C Boike, M J Rybak, J E Tintinalli, et al.
Antimicrobial Agents and Chemotherapy
|
October 19, 2000
Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model
J R Aeschlimann, G P Allen, E Hershberger, et al.
Antimicrobial Agents and Chemotherapy
|
June 30, 2010
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates
Kimberly D Leuthner, Celine Vidaillac, Chrissy M Cheung, et al.
Pharmacotherapy
|
November 11, 1999
Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside
K R Murry, P S McKinnon, B Mitrzyk, et al.
Antimicrobial Agents and Chemotherapy
|
March 11, 2015
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models
Jordan R Smith, Katie E Barber, Animesh Raut, et al.
Page
of 54